SION - Sionna Therapeutics, Inc.

35.93
1.370   3.813%

Share volume: 310,437
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%
$34.56
1.37
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
41%
Profitability 35%
Dept financing 19%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
5.40%
1 Month
-2.42%
3 Months
-11.76%
6 Months
66.19%
1 Year
141.14%
2 Year
43.72%
Key data
Stock price
$35.93
P/E Ratio 
N/A
DAY RANGE
$32.77 - $36.22
EPS 
$408.12
52 WEEK RANGE
$7.26 - $45.00
52 WEEK CHANGE
$141.14
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
44.998 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$278,469
AVERAGE 30 VOLUME 
$254,214
Company detail
CEO: Michael Cloonan
Region: US
Website: www.sionnatx.com
Employees: 35
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients. Our principal executive offices are located in Waltham, MA.

Recent news